SOTERIA BIOTHERAPEUTICS
Soteria is developing a next generation of conditionally active bispecific t-cell engaging antibodies to treat cancer patients with solid tumors. Soteria’s highly innovative T-LITE™ platform provides small molecule-dependent activation of bispecific antibody therapies, enabling safer and more efficacious treatments through pulsatile activity, reduced side effects and higher dosing.
SOTERIA BIOTHERAPEUTICS
Social Links:
Industry:
Biopharma Biotechnology Health Care
Founded:
2018-01-01
Address:
San Francisco, California, United States
Country:
United States
Website Url:
http://www.soteriabiotherapeutics.com
Total Employee:
11+
Status:
Active
Email Addresses:
[email protected]
Total Funding:
42 M USD
Similar Organizations
Rakuten Medical
Rakuten Medical is a Bio-technology Company.
Day One Biopharmaceuticals
Day One Biopharmaceuticals is a biotechnology company that focuses on developing new cancer therapies for patients of all ages.
Novellus
Novellus is a biotechnology company working to develop engineered cellular medicines.
Soligenix
Soligenix is a biopharmaceutical company that develops biodefense vaccines and therapeutics to treat rare diseases.
Current Employees Featured
Founder
Investors List
Alexandria Venture Investments
Alexandria Venture Investments investment in Series A - Soteria Biotherapeutics
M Ventures
M Ventures investment in Series A - Soteria Biotherapeutics
5AM Ventures
5AM Ventures investment in Series A - Soteria Biotherapeutics
Novartis Venture Fund
Novartis Venture Fund investment in Series A - Soteria Biotherapeutics
Roche Venture Fund
Roche Venture Fund investment in Series A - Soteria Biotherapeutics
Official Site Inspections
http://www.soteriabiotherapeutics.com
- Host name: 104.21.63.7
- IP address: 104.21.63.7
- Location: United States
- Latitude: 37.751
- Longitude: -97.822
- Timezone: America/Chicago
More informations about "Soteria Biotherapeutics"
Soteria Biotherapeutics - Crunchbase Company Profile & Funding
Soteria is a biotechnology company that develops immunotherapies to treat cancer patientsSee details»
Soteria Biotherapeutics - LinkedIn
Soteria Biotherapeutics Biotechnology Research San Mateo, California 2,536 followers We are developing next-generation immunotherapies with improved efficacy and safety.See details»
Soteria Biotherapeutics Company Profile | Management and
Company Name. Soteria Biotherapeutics. Main Industry. Research & Development, Business Services. Website. www.soteriabiotherapeutics.comSee details»
Soteria Biotherapeutics, Inc. - Dun & Bradstreet
Find company research, competitor information, contact details & financial data for Soteria Biotherapeutics, Inc. of San Francisco, CA. Get the latest business insights from Dun & …See details»
Soteria Biotherapeutics - PitchBook
Information on valuation, funding, cap tables, investors, and executives for Soteria Biotherapeutics. Use the PitchBook Platform to explore the full profile.See details»
Soteria Biotherapeutics Launches with $42 Million Series A …
May 17, 2021 Soteria Biotherapeutics Launches with $42 Million Series A Financing Led by Roche Venture Fund and 5AM Ventures Proceeds to fund early pipeline of novel switchable …See details»
Soteria Biotherapeutics - VentureRadar
May 8, 2019 Similar Companies: Cellenkos USA Privately Held Cellenkos is an early stage clinical biotechnology company that focuses on umbilical cord blood derived T-regulatory …See details»
Soteria Company Profile - Office Locations, Competitors ... - Craft
Soteria has 5 employees at their 1 location and $42 m in total funding,. See insights on Soteria including office locations, competitors, revenue, financials, executives, subsidiaries and more …See details»
Soteria Biotherapeutics - VentureRadar
Soteria Biotherapeutics is developing next-generation T-cell therapies, with improved efficacy and safety, for the treatment of cancer. ... Find out more about Soteria Biotherapeutics, Biotech …See details»
Overview, News & Similar companies - ZoomInfo.com
May 16, 2021 Soteria Biotherapeutics contact info: Phone number: (415) 514-4498 Website: www.soteriabiotherapeutics.com What does Soteria Biotherapeutics do? Soteria is developing …See details»
Soteria Biotherapeutics - Products, Competitors, Financials, …
May 18, 2021 Ball succeeds Maderis as CEO of Antiva. Apr 29, 2023. Ball succeeds Maderis as CEO of Antiva Plus: Valente joins Xencor and updates from Sutro, Gameto and more By …See details»
Soteria Biotherapeutics Announces Scientific Advisory Board - PR …
Nov 12, 2020 Soteria Biotherapeutics Announces Scientific Advisory Board Preeminent Leaders in Antibody and Cancer Immunotherapy Discovery and Development to Advise Company's …See details»
Soteria Biotherapeutics Launches with $42 Million Series A …
Read original article at PR Newswire. SAN FRANCISCO, May 17, 2021 /PRNewswire/ — Soteria Biotherapeutics, Inc. (“Soteria”), a privately-held, immuno-oncology company focused on …See details»
Soteria Biotherapeutics Announces Scientific Advisory Board
SAN FRANCISCO, Nov. 12, 2020: Soteria Biotherapeutics, Inc. ("Soteria"), a privately-held, immuno-oncology company focused on developing a next generation of conditionally active …See details»
Soteria Biotherapeutics Launches with $42 Million Series A
SAN FRANCISCO, May 17, 2021 /PRNewswire/ -- Soteria Biotherapeutics, Inc. (“Soteria”), a privately-held, immuno-oncology company focused on developing a next generation of …See details»
Soteria Biotherapeutics Launches with $42 Million Series A …
SAN FRANCISCO, May 17, 2021 /PRNewswire/ -- Soteria Biotherapeutics, Inc. ('Soteria'), a privately-held, immuno-oncology company focused on develo...See details»
Soteria Launches with $42 Million in Series A Financing
May 17, 2021 Soteria Biotherapeutics, Inc. a privately-held, immuno-oncology company focused on developing a next generation of switchable bispecific T-cell engagers to treat patients with …See details»
Soteria Biotherapeutics - CB Insights
Soteriabiotherapeutics.com. Overview & Products; Financials; People; Alternatives & Competitors; Executives 5. Soteria Biotherapeutics Management Team5 Team Members. Soteria …See details»
Soteria Biotherapeutics Launches with $42 Million Series A …
May 17, 2021 Soteria was founded in 2018 with technology licensed from UC San Francisco and is based in San Francisco, California. For additional information, visit …See details»
Soteria raises $42M series A to develop switchable bispecific T-cell ...
May 17, 2021 Soteria Biotherapeutics Inc., a company developing switchable bispecific T-cell engagers to treat patients with solid tumors, has raised $42 million in series A financing to fund …See details»